Press ReleaseParasites – beneficiaries of Climate Change
Risk of infectious diseases rises above all for dogs
15. May 2007 The tick season used to be from April to October, but in future animal owners should comb through their four-legged companions’ fur to check for dangerous parasites all year round.Leverkusen – Alarm bells are ringing: the mild winter in many parts of the northern hemisphere is causing concern among many experts that a parasite plague is imminent. What’s more, tropical parasites are advancing further and further into temperate climate regions such as Europe or North America as a result of global climate change. The risk is particularly great for dogs, which often come into contact with ticks, sandflies or mosquitoes, because these parasites can transmit dangerous infectious diseases. That’s why suitable protective measures are becoming increasingly important. CVBD World Forum:The CVBD World Forum is a panel of experts comprising leading scientists, veterinarians and physicians from Europe, the United States, Australia and Asia. It was established during the First International CVBD Symposium held in April 2006 in Billesley, United Kingdom, as a reaction to the global increase in canine vector-borne diseases (CVBD). The main goals of the CVBD World Forum are to promote the exchange of conventional and new knowledge about the interplay between ectoparasites, pathogens and their hosts; to describe and evaluate the distribution of parasites and pathogens in order to facilitate specific regional risk analyses; and to support suitable preventative measures. These activities are supported by the Animal Health Division of Bayer HealthCare. Further information can be found on the Internet at www.cvbd.org. Bayer HealthCareBayer HealthCare, a subsidiary of Bayer AG, is one of the world’s leading, innovative companies in the healthcare and medical products industry and is based in Leverkusen, Germany. The company combines the global activities of the Animal Health, Consumer Care, Diabetes Care and Pharmaceuticals divisions. The pharmaceuticals business operates under the name Bayer Schering Pharma AG. Bayer HealthCare’s aim is to discover and manufacture products that will improve human and animal health worldwide. With sales of EUR 905 million (2006) the Animal Health Division is one of the world’s leading manufacturers of veterinary drugs. The division manufactures and markets approximately 100 different veterinary drugs and care products for food-supplying animals and companion animals (dogs, cats, horses). Forward-looking statementsThis news release contains forward-looking statements based on current assumptions and forecasts made by Bayer Group management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in our public reports filed with the Frankfurt Stock Exchange and with the U.S. Securities and Exchange Commission (including our Form 20-F). The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments. |
ServicesContact for specific questionsVeterinary ServiceMore ServicesFAQs and LinksGalleryImages Image/Graphic Download
ContactText 2007-05-Parasiten-E.pdf 104 KB
2007-05-Parasiten-E.rtf 9992 KB
2007-05-Parasiten-D.pdf 101 KB
2007-05-Parasiten-D.rtf 9996 KB
|
|